| Availability Dates |
Title |
Credit Hours |
|
May 26, 2020 - May 31, 2021
|
2020 Virtual Meeting: Comorbidities and MS: Critical Thinking about DMT's and Vaccines
|
1.00 |
|
May 27, 2020 - May 31, 2021
|
2020 Virtual Meeting: Current Perspectives of Pediatric Care and Research
|
1.00 |
|
May 29, 2020 - May 31, 2021
|
2020 Virtual Meeting: The Role of Biological Aging In MS Progression
|
1.00 |
|
May 29, 2020 - May 31, 2021
|
2020 Virtual Meeting: The Role of Complement in MS
|
1.00 |
|
May 26, 2020 - May 31, 2021
|
2020 Virtual Meeting: Whitaker Lecture: CNS Immune Responses that Underlie Progressive MS: Future Challenges in the COVID-19 Era
|
1.00 |
|
May 29, 2020 - May 31, 2021
|
2020 Virtual Meeting: A Clinician's Guide to Cognition in MS
|
1.00 |
|
May 28, 2020 - May 31, 2021
|
2020 Virtual Meeting: Cannabis and MS: Efficacy, Safety, Drug Interactions, and Research Update
|
1.00 |
|
May 29, 2020 - May 31, 2021
|
2020 Virtual Meeting: Caring for Women Across the Reproductive Lifespan
|
1.00 |
|
May 27, 2020 - May 31, 2021
|
2020 Virtual Meeting: Depression and MS: Diagnosing and Treating
|
1.00 |
|
May 28, 2020 - May 31, 2021
|
2020 Virtual Meeting: Emerging Therapies Across the Disease Spectrum
|
1.00 |
|
May 29, 2020 - May 31, 2021
|
2020 Virtual Meeting: Genetics Update
|
1.00 |
|
May 27, 2020 - May 31, 2021
|
2020 Virtual Meeting: Importance of Assessing Nutritional Health in Patients with MS
|
1.00 |
|
May 28, 2020 - May 31, 2021
|
2020 Virtual Meeting: John F. Kurtzke Lecture: Stem Cell Research Update
|
1.00 |
|
May 26, 2020 - May 31, 2021
|
2020 Virtual Meeting: Neuromyelitis Optica Spectrum Disorders: Emerging Treatment Options
|
1.00 |
|
May 26, 2020 - May 31, 2021
|
2020 Virtual Meeting: Progressive MS: Diagnosis, Clinical Course and Long-Term Management
|
1.00 |
|
May 27, 2020 - May 31, 2021
|
2020 Virtual Meeting: Rehabilitation in MS: That was Then, This is Now
|
1.00 |
|
May 26, 2020 - May 31, 2021
|
2020 Virtual Meeting: Science, Art, and Practice of Behavioral Medicine
|
1.00 |
|
May 28, 2020 - May 31, 2021
|
2020 Virtual Meeting: Use of Psychotropics in MS: Antidepressants, Antianxiety Agents, Mood Stabilizers, Hypnotics, Antipsychotics, and Cognitive Enhancers
|
1.00 |
|
February 24, 2020 - February 25, 2021
|
A 30‐Year Clinical and Magnetic Resonance Imaging Observational Study of Multiple Sclerosis and Clinically Isolated Syndromes
|
1.00 |
|
June 1, 2020 - June 1, 2021
|
Clinically Assessed Walking Capacity Versus Real-World Walking Performance in People with Multiple Sclerosis
|
1.00 |
|
January 28, 2020 - January 29, 2021
|
Counseling Women with MS in Middle Age and the Postmenopausal Years
|
1.00 |
|
October 1, 2019 - October 1, 2020
|
Experience of Identity Change in People Who Reported a Diagnosis of Multiple Sclerosis: A Qualitative Inquiry
|
1.00 |
|
December 1, 2019 - December 1, 2020
|
How Can We Apply Guidelines in the Rapidly Changing MS Treatment Landscape?
|
1.00 |
|
August 20, 2019 - August 1, 2020
|
Perspectives About Time Frames in Stem Cell Research for Multiple Sclerosis: "Time Is Brain"
|
1.00 |
|
February 1, 2020 - February 1, 2021
|
Perspectives of People with Multiple Sclerosis About Helminth Immunotherapy
|
1.00 |
|
April 1, 2020 - April 2, 2021
|
Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
|
1.50 |
|
February 1, 2020 - February 28, 2021
|
Reproductive Health Planning For Patients With Multiple Sclerosis (Supplement)
|
1.00 |
|
December 12, 2019 - December 31, 2020
|
Reproductive Health Planning for Patients with Multiple Sclerosis: A Clinician's Guide (Webinar)
|
1.00 |
|
November 30, 2019 - November 30, 2020
|
Stabilization without Rituximab after Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature Overview
|
1.00 |
|
February 19, 2020 - February 21, 2021
|
The Art of Multiple Sclerosis Therapies: Applying Immunologic Principles in MS
|
2.00 |
|
July 8, 2020 - July 31, 2021
|
The COVID-19 Pandemic and the Use of MS Disease Modifying Therapies
|
1.00 |
|
June 1, 2020 - June 1, 2021
|
The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis
|
1.25 |
|
December 1, 2019 - December 1, 2020
|
Toward Digital Self-monitoring of Multiple Sclerosis: Investigating First Experiences, Needs, and Wishes of People with MS
|
0.75 |
| Back To Top |
